Please assess the completion status of the following clinical trial:

Trial Title: Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Individuals older than 18 years who score a 12 or greater on the Reflux Disease Questionnaire and have failed a four week trial of daily proton pump inhibitor.~2. Subjects without gastroesophageal reflux disease (GERD) undergoing upper endomicroscopy for other indications will be recruited into study as controls.~Exclusion Criteria:~1. Barrett's esophagus~2. Use of twice daily proton pump inhibitor within 4 weeks of study entry~3. Esophageal varices~4. Coagulopathy (aspirin, NSAIDS and Plavix are allowed. Coumadin, Xarelto, heparin are not allowed.)~5. Gastrointestinal cancer or mass~6. Previous surgery involving the esophagus, stomach or duodenum~7. Pregnancy~8. Allergy to either sucralfate or proton pump inhibitors

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Proton Pump Inhibitor (PPI) Therapy (Type: OTHER): 2x daily Proton Pump Inhibitor (PPI) Therapy for 8 weeks
- Sucralfate (Type: OTHER): 4x daily Sucralfate slurry, 1g, for 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).